MicroTransponder, Inc.
MicroTransponder is dedicated to improving the quality of life for patients with chronic neurological conditions through its innovative Paired Vagus Nerve Stimulation (VNS) platform. Their FDA-approved Vivistim System aims to help stroke survivors regain arm and hand motor function by leveraging neuroplasticity. The company emphasizes patient-centered care, embracing challenges, and maintaining flexibility in its operations. With a strong leadership team and a commitment to compliance and innovation, MicroTransponder continues to advance stroke rehabilitation technology.
Industries
Nr. of Employees
small (1-50)
MicroTransponder, Inc.
2802 Flintrock Trace, Suite 226, Austin, TX 78738
Patents
Methods for enhancing exposure therapy using pairing with Vagus nerve stimulation
US-12064563-B2
View DetailsMethods for enhancing exposure therapy using pairing with vagus nerve stimulation
US-10213577-B2
View Details
Methods for enhancing exposure therapy using pairing with Vagus nerve stimulation
US-12064563-B2
View DetailsMethods for enhancing exposure therapy using pairing with vagus nerve stimulation
US-10213577-B2
View DetailsProducts
Implantable paired vagus nerve stimulation system for post-stroke upper-limb rehabilitation
An implantable neurostimulation system designed to stimulate the vagus nerve in coordination with rehabilitation exercises to improve hand and arm motor function in chronic ischemic stroke patients.
Implantable paired vagus nerve stimulation system for post-stroke upper-limb rehabilitation
An implantable neurostimulation system designed to stimulate the vagus nerve in coordination with rehabilitation exercises to improve hand and arm motor function in chronic ischemic stroke patients.
Services
Design and conduct of randomized pivotal trials and registries for neuromodulation therapies, including trial operations and publication support.
Preparation and management of FDA PMA and IDE submissions and interactions with regulatory authorities for implantable neurostimulation devices.
Development of payer engagement strategies, coding solutions, and applications for CMS and commercial coverage.
Provision of training for surgeons and rehabilitation clinicians on implantation procedures and paired-stimulation therapy delivery, including facility-based sessions.
Establishment of written policies, training, auditing, and reporting mechanisms to align promotional activities with federal and state legal requirements and industry codes.
Design and conduct of randomized pivotal trials and registries for neuromodulation therapies, including trial operations and publication support.
Preparation and management of FDA PMA and IDE submissions and interactions with regulatory authorities for implantable neurostimulation devices.
Development of payer engagement strategies, coding solutions, and applications for CMS and commercial coverage.
Provision of training for surgeons and rehabilitation clinicians on implantation procedures and paired-stimulation therapy delivery, including facility-based sessions.
Establishment of written policies, training, auditing, and reporting mechanisms to align promotional activities with federal and state legal requirements and industry codes.
Expertise Areas
- Stroke rehabilitation neuromodulation
- Clinical trial management for implantable devices
- Regulatory affairs (PMA and IDE pathways)
- Reimbursement and market access strategy
Key Technologies
- Vagus nerve stimulation (VNS)
- Implantable neurostimulation systems
- Implantable peripheral nerve leads
- Paired stimulation synchronized with therapy/training
News & Updates
Recognized for the Vivistim Paired VNS System as one of the best inventions in medical care.
Won the Edison Award for the Vivistim Paired VNS System, a game-changer for stroke survivors.
Recognized for the Vivistim Paired VNS System as one of the best inventions in medical care.
Won the Edison Award for the Vivistim Paired VNS System, a game-changer for stroke survivors.